The biological metrics that reveal how our bodies age
By
brandonb
If you only eat one bagel today, this is the bagel.
Summary
The article explores the subtle, measurable biological changes that occur as we age, focusing on objective metrics like kidney filtration rate, VO2 max, grip strength, and other physiological markers. It highlights that while most metrics decline gradually over decades, kidney filtration drops nearly twice as fast as other markers rise. Notably, a subset of people in their seventies maintain kidney function levels comparable to a thirty-year-old, suggesting that aging trajectories vary significantly between individuals.
Key quotes
· 5 pulledYeats wrote of an aged man as 'a tattered coat upon a stick.' But for most of us, aging comes as small diminishments.
The body is keeping score long before we are.
None of these metrics move more than a few percent in a year, but stacked across decades, they describe an aging body.
Kidney filtration falls almost twice as fast as any other lab marker rises.
A quiet subset of people in their seventies hold the levels of a thirty-year-old.
You might also wanna read
Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds
An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug blocks
Woman develops whiplike rash on back after eating shiitake mushrooms
A woman developed bright-red, whiplike rashes on her back after eating shiitake mushrooms, a condition known as shiitake dermatitis. The cas
livescience.com·2h agoMolecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
Molecular glue approach doubles survival time for aggressive pancreatic cancer patients
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds
An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug works b

Senolytic treatment linked to oligodendrocyte dysfunction and demyelination in brain study
This scientific research article investigates the effects of senolytic treatment (dasatinib and quercetin combination) on the corpus callosu
